The ePRO, epatient diaries, and eCOA market was valued at US$ 1,342.92 million in 2020 and it is projected to reach US$ 4,130.35 million by 2028; it is expected to grow at a CAGR of 15.08% during 2020-2028. Increasing demand for electronic health records (EHRs) and rising use of smartphones are fueling the market growth. However, concerns regarding data privacy is hindering the growth of the ePRO, epatient diaries, and eCOA market.
The usage of electronic Clinical Outcome Assessment (eCOA) is a push toward adapting the ‘new normal’ as it is a method to gather patient data electronically by using technologies such as smart home devices, handheld monitors, wearables, e-diaries, tablets, and web servers to allow the stakeholders (patients, healthy volunteers, investigators and caregivers) in the trials to report outcomes directly and digitally.Although historically COA was only related to the evaluation of Patient-Related Outcomes (PRO), the FDA has now broadened the definition to include PerfO, ClinRO, and ObsRO along with PRO.
In simple terms, when the above parameters are reported electronically, they fit under the eCOA spectrum.
eCOA/ePRO platform has substantial benefits for sponsors and CROs, as it reduces administrative burden, mitigates cost, and fastens trials. Such system shows strong results with fewer errors and discrepancies, improved data quality, clearer signals, and standardized accurate studies. The factors such as the increasing adoption of EHR and government regulations mandating the maintenance of health records drive the growth of the ePRO, epatient diaries, and eCOA market.
The global ePRO, epatient diaries, and eCOA market is segmented on the basis of type of solution, modality, and end user.Based on type of solution, the market is segmented into eCOA (Electronic Clinical Outcome Assessments), ePROs (Patient Reported Outcomes), ClinROs (Clinician Reported Outcomes), ObsROs (Observer Reported Outcomes), PerfOs (Performance Outcomes), and E-Patient Diaries.
The eCOA segment held the largest share of the market in 2020.However, the ePRO segment is estimated to register the highest CAGR in the market during the forecast period.
Based on modality, the ePRO, epatient diaries, and eCOA market is bifurcated into computer and mobile devices.The mobile devices segment held a larger share of the market in 2020.
Also, the same segment is estimated to register a higher CAGR in the market during the forecast period. By end user, the ePRO, epatient diaries, and eCOA market is segmented into clinical trial sponsors, contract research organizations (CROs), hospitals, academic institutes, pharmaceutical companies, and others. The clinical trial sponsors segment held the largest share of the market in 2020, and it is estimated to register the highest CAGR of 15.5% in the market during the forecast period.
Center for Patient and Consumer Engagement, Society for Participatory Medicine, Association for Patient Experience, Institute of Patient and Family Centered Care, Patient Engagement Advisory Committee, and American Association of Healthcare Administrative Management (AAHAM) are among the primary and secondary sources referred to while preparing the report on the ePRO, epatient diaries, and eCOA market.
Our reports have been used by over 10K customers, including:
The ePRO, ePatient Diaries, and eCOA market in Europe is expected to grow from US$ 447.8 million in 2021 to US$ 1,184.3 million by 2028; it is estimated to grow at a CAGR of 14.9% from 2021 to 2028. As per the data provided by Clinicaltrials.gov, 2016 has been a big one for clinical research. There were around 366 thousand clinical studies...
The global microplate systems market size is projected to reach USD 1,170 million by 2026 from USD 927 million in 2021, at a CAGR of 4.8% from 2021 to 2026. Growth in this market is driven by the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, and the growing prevalence of diseases Microplate...
The ePRO, ePatient Diaries, and eCOA market in South and Central America is expected to grow from US$ 90.3 million in 2021 to US$ 229.0 million by 2028; it is estimated to grow at a CAGR of 14.2% from 2021 to 2028. Patient centricity means designing a treatment, clinical trial, or other health solution centered around the patient. Creating...
The ePRO, ePatient diaries, and eCOA market in Asia Pacific is expected to grow from US$ 348.8 million in 2021 to US$ 964.2 million by 2028; it is estimated to grow at a CAGR of 15.6% from 2021 to 2028. Healthcare systems are experiencing a rise in consumer engagement worldwide. In developing countries, health care systems are becoming more...
The ePRO, ePatient Diaries, and eCOA market in Middle East and Africa is expected to grow from US$ 48.4 million in 2021 to US$ 112.3 million by 2028; it is estimated to grow at a CAGR of 12.8% from 2021 to 2028. Increasing number of smartphone users is likely to boost the ePRO, e-Patient Diaries, and eCOA’s adoption in the coming years. Mobile-enabled...
The ePRO, ePatient Diaries, and eCOA market in North America is expected to grow from US$ 607.2 million in 2021 to US$ 1,640.6 million by 2028; it is estimated to grow at a CAGR of 15.3% from 2021 to 2028. Increasing number of smartphone users is likely to boost the ePRO, e-Patient Diaries, and eCOA’s adoption in the coming years. As per the...
The cardiac rehabilitation market is expected to reach US$ 2,865.42 million by 2028 from US$ 1,780.98 million in 2020; it is estimated to grow at a CAGR of 6.12% during 2020-2028. The growth of the market is mainly attributed to the key driving factors such as the rising incidences of cardiovascular diseases and growing adoption of tele-cardiac...
The Formulation Development Outsourcing market was valued at approximately USD 8,055 million in 2020 and is expected to witness a revenue of USD 12,650 million in 2026, with a CAGR of 7.2% over the forecast period. The rapidly evolving threat of COVID-19 is impacting lives, communities, businesses, and industries around the world. The...
The global healthcare BPO market is projected to reach USD 468.5 billion by 2026 from USD 296.4 billion in 2021, at a CAGR of 9.6% during the forecast period. Healthcare BPO is a practice in which healthcare organizations outsource their business operations to third-party organizations. The aim of healthcare business process outsourcing services...
This IDC Perspective provides IDC Health Insights' overview of key IT deals, news, and digital initiatives in the European life sciences and pharma industries in Q1 2021. In the evolving COVID-19 scenario, it is critical for European life sciences companies and their technology suppliers to closely follow the fast-moving trends and developments...
Medical Technology Density
Prescription Drug Sales
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.